ALNY : Analysis & Opinions

  1. Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog

    December 15, 2014
    Alnylam (ALNY) announced a strategy for developing its RNAi therapeutics in three strategic therapeutic areas (STArs): genetic ...
  2. These Healthcare Stocks Remain Strong Bets

    September 30, 2014
    Healthcare continues to perform strongly, holding up well during the recent stock index pullback. Here are four healthcare ...
  3. 8 Stages Of New Drug Development

    July 29, 2013
    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these ...
  4. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  5. Alnylam-ISIS Venture Prices IPO - Analyst Blog

    October 5, 2012
    Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently announced ...
  6. Company News for July 17, 2012 - Corporate Summary

    July 17, 2012
    "    Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged 53% following positive results from its Phase I trial of ...
  7. How the Short Ratio Can Lead to Big Gains - Screen of the Week

    June 12, 2012
    This week's Screen looks at a market sentiment indicator called the 'Short Ratio' to find new stock picks. The short ratio ...
  8. Good IPO, Bad IPO

    June 17, 2009
    A good IPO will consider the needs of long-time investors as well as new ones. Here is the good the bad about two IPOs.
Trading Center